5-(2-[<sup>18</sup>F]FLUOROETHYL)-4-METHYLTHIAZOLE PROBE FOR POSITRON EMISSION TOMOGRAPHY OF THE CENTRAL NERVOUS SYSTEM

Authors

  • N. M. Evdokimov University of California, Los Angeles
  • G. Flores University of California, Los Angeles, Department of Molecular and Medical Pharmacology
  • P. M. Clark University of Calfornia, Los Angeles, Department of Microbiology, Immunology, and Molecular Genetics,
  • M. E. Phelps University of California, Los Angeles, Department of Molecular and Medical Pharmacology
  • O. N. Witte University of California, Los Angeles, Department of Molecular and Medical Pharmacology
  • M. E. Jung University of California, Los Angeles, Department of Chemistry and Biochemistry

DOI:

https://doi.org/10.1007/1468

Keywords:

5-(2-[18F]fluoroethyl)-4-methylthiazole, central nervous system, fluorination, imaging, neuroprotection, positron emission tomography, radiolabeling

Abstract

How to Cite
Evdokimov, N. M.; Flores, G.; Clark, P. M.; Phelps, M. E.; Witte, O. N.; Jung, M. E. Chem. Heterocycl. Compd. 2014, 50, 303. [Khim. Geterotsikl. Soedin. 2014, 330.]

For this article in the English edition see DOI 10.1007/s10593-014-1477-4

Published

2014-02-26

Issue

Section

Letters to the Editor